Please Note:
This profile was automatically generated using 21 references found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 21 references found on the Internet. This information has not been verified. Learn more...
View all 21 references Web References
-
1. Leon Aarons BSc, MSc, PhD (Pharmacy and Pharmaceutical Sciences - University of Manchester)
www.pharmacy.manchester.ac.uk/ - [Cached]Published on: 8/27/2008 Last Visited: 8/27/2008
Dr Leon Aarons
...
Professor Leon Aarons BSc, MSc, PhD
...
Photograph of Leon AaronsProfessor of Pharmacometrics
Email: leon.aarons@manchester.ac.ukTelephone: +44 (0)161 275 2357Fax: 0161 275 8349
...
Professor Leon Aarons is a Professor in the School of Pharmacy and Pharmaceutical Sciences at the University of Manchester, UK.Following a postdoctoral fellowship at the School of Chemistry, University of Leeds, he came to Manchester in 1976.
His major research interests lie in the area of pharmacokinetics.He has a general interest in the subject as a whole but has a special interest in data analysis and interpretation.He collaborates with members of the pharmacokinetic group in Manchester and also with other scientists in industry and academia throughout Europe.His current activities revolve around population pharmacokinetics.People involved in the drug development process are becoming increasingly aware of the importance of studying the pharmacokinetic and pharmacodynamics of the drug in the population interest as soon as possible.
He is a member on various committees promoting research including the United Kingdom Pharmacokinetic Discussion Group and is a member of the management committee of COST B25.
He is European Editor of the Journal of Pharmacokinetics and Pharmacodynamics and Executive Editor of the British Journal of Clinical Pharmacology. -
2. www.pkworkshops.com
www.pkworkshops.com/aarons.htm - [Cached]Published on: 11/13/2007 Last Visited: 11/13/2007
Prof Leon Aarons is a Professor and Director of Undergraduate Studies in the School of Pharmacy and Pharmaceutical Sciences at the University of Manchester, UK.Following a postdoctoral fellowship at the School of Chemistry, University of Leeds, he came to Manchester in 1976.
His major research interests lie in the area of pharmacokinetics.He has a general interest in the subject as a whole but has a special interest in data analysis and interpretation.He collaborates with members of the pharmacokinetic group in Manchester and also with other scientists in industry and academia throughout Europe.His current activities revolve around population pharmacokinetics.People involved in the drug development process are becoming increasingly aware of the importance of studying the pharmacokinetic and pharmacodynamics of the drug in the population interest as soon as possible.
He is a member on various committees promoting research including the United Kingdom Pharmacokinetic Discussion Group and is a member of the management committee of COST B15.
He is Co-Editor of the Journal of Pharmacokinetics and Pharmacodynamics and Executive Editor of the British Journal of Clinical Pharmacology. -
3. Leon Aarons BSc, MSc, PhD (Pharmacy and Pharmaceutical Sciences - University of Manchester)
www.pharmacy.manchester.ac.uk/ - [Cached]Published on: 8/27/2008 Last Visited: 8/27/2008
Photograph of Leon AaronsProfessor of Pharmacometrics
Email: leon.aarons@manchester.ac.ukTelephone: +44 (0)161 275 2357Fax: 0161 275 8349
...
Professor Leon Aarons is a Professor in the School of Pharmacy and Pharmaceutical Sciences at the University of Manchester, UK.Following a postdoctoral fellowship at the School of Chemistry, University of Leeds, he came to Manchester in 1976.
His major research interests lie in the area of pharmacokinetics.He has a general interest in the subject as a whole but has a special interest in data analysis and interpretation.He collaborates with members of the pharmacokinetic group in Manchester and also with other scientists in industry and academia throughout Europe.His current activities revolve around population pharmacokinetics.People involved in the drug development process are becoming increasingly aware of the importance of studying the pharmacokinetic and pharmacodynamics of the drug in the population interest as soon as possible.
He is a member on various committees promoting research including the United Kingdom Pharmacokinetic Discussion Group and is a member of the management committee of COST B25.
He is European Editor of the Journal of Pharmacokinetics and Pharmacodynamics and Executive Editor of the British Journal of Clinical Pharmacology.
